Some of the top global pharmaceutical companies have left Pakistan due to a revision of their business plan, rupee depreciation and due to competition with the local pharmaceutical companies. According to senior representatives of the Pakistan Pharmaceutical Manufacturing Association (PPMA) and officials of the Federal Ministry for National Health Services and Regulations (NHSR) most of these c